Factors associated with early lung cancer mortality: a systematic review

References

• World Health Organization, Cancer Fact Sheet No. 297. http://www.who.int/mediacentre/factsheets/fs297/en/
   Google Scholar
• Bradley CJ, Yabroff KR, Mariotto AB, et al. Antineoplastic treatment of advanced-stage non–small-cell lung cancer: treatment, survival, and spending (2000 to 2011). J Clin Oncol. 2017;35(5):529–535.
   PubMed Web of Science ®Google Scholar
• Planchard D, Popat S, Kerr K, et al. Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;4:iv192–iv237.
   Google Scholar
• Warner A, Dahele M, Hu B, et al. Factors associated with early mortality in patients treated with concurrent chemoradiation therapy for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2016;94(3):612–620. .
   PubMed Web of Science ®Google Scholar
• Klement RJ, Belderbos J, Grills I, et al. Prediction of early death in patients with early-stage NSCLC—can we select Patients without a Potential Benefit of SBRT as a curative treatment approach? J Thorac Oncol. 2016;11(7):1132–1139. .
   PubMed Web of Science ®Google Scholar
• McPhail S, Johnson S, Greenberg D, et al. Stage at diagnosis and early mortality from cancer in England. Br J Cancer. 2015;112(Suppl S1):S108–S115.
   PubMedGoogle Scholar
• Chouaïd C, Debieuvre D, Durand-Zaleski I, et al. Survival inequalities in patients with lung cancer in France: a nationwide cohort study (the TERRITOIRE Study). PLoS One. 2017;12(8):e0182798.
   PubMed Web of Science ®Google Scholar
• Kawaguchi T, Takada M, Kubo A, et al. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC. J Thorac Oncol. 2010;5(5):620–630.
   PubMed Web of Science ®Google Scholar
• O’Dowd EL, McKeever TM, Baldwin DR, et al. What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK? Thorax. 2015;70(2):161–168. .
   PubMed Web of Science ®Google Scholar
• Morgensztern D, Samson PS, Waqar SN, et al. Early mortality in patients undergoing adjuvant chemotherapy for non–small cell lung cancer. J Thorac Oncol. 2018;13(4):543–549.
   PubMed Web of Science ®Google Scholar
• Wallington M, Saxon EB, Bomb M, et al. 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study. Lancet Oncol. 2016;17(9):1203–1216.
   PubMed Web of Science ®Google Scholar
• Powell HA, Tata LJ, Baldwin DR, et al. Early mortality after surgical resection for lung cancer: an analysis of the english national lung cancer audit. Thorax. 2013;68(9):826–834.
   PubMed Web of Science ®Google Scholar
• Melvan JN, Sancheti MS, Gillespie T, et al. Nonclinical factors associated with 30-day mortality after lung cancer resection: an analysis of 215,000 Patients Using the National Cancer Data Base. J Am Coll Surg. 2015;221(2):550–563. .
   PubMed Web of Science ®Google Scholar
• Amini A, Verma V, Glaser SM, et al. Early mortality of stage IV non-small cell lung cancer in the United States. Acta Oncol. 2019;58(8):1095–1101.
   PubMed Web of Science ®Google Scholar
• Haque W, Verma V, Butler EB, et al. Post-treatment mortality after definitive chemoradiotherapy versus trimodality therapy for locally advanced non-small cell lung cancer. Lung Cancer. 2019;127:76–83.
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Tamura T, Fukuoka M, et al. Survival and prognostic factors in lung cancer patients treated in phase I trials: japanese experience. Int J Oncol. 1999;15(4):737–741.
   PubMed Web of Science ®Google Scholar
• Gibson AJW, Li H, D’Silva A, et al. Factors associated with early mortality in non-small cell lung cancer patients following systemic anti-cancer therapy: a 10 year population-based study. Lung Cancer. 2019;134:141–146.
   PubMed Web of Science ®Google Scholar
• Christensen NL, Løkke A, Dalton SO, et al. Smoking, alcohol, and nutritional status in relation to one-year mortality in Danish stage I lung cancer patients. Lung Cancer. 2018;124:40–44.
   PubMed Web of Science ®Google Scholar
• Christensen NL, Kejs AMT, Jakobsen E, et al. Early death in Danish stage I lung cancer patients: a population-based case study. Acta Oncol. 2018;12(11):1561–1566.
   Google Scholar
• Currow DC, You H, Aranda S, et al. What factors are predictive of surgical resection and survival from localised non-small cell lung cancer? Med J Aust. 2014;201(8):475–480.
   PubMed Web of Science ®Google Scholar
• Inoue T, Tamiya M, Tamiya A, et al. Analysis of early death in japanese patients with advanced non–small-cell lung cancer treated with nivolumab. Clin Lung Cancer. 2018;19(2):e171–e176. .
   PubMed Web of Science ®Google Scholar
• Lassen UN, Osterlind K, Hirsch FR, et al. Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression. Br J Cancer. 1999;79(3–4):515–519.
   PubMed Web of Science ®Google Scholar
• Grivaux M, Debieuvre D, Herman D, et al. Early mortality in lung cancer: french prospective multicentre observational study. BMC Pulm Med. 2016;16(1):45.
   PubMedGoogle Scholar
• Quoix E, Monnet I, Scheid P, et al. [Management and outcome of French elderly patients with lung cancer: an IFCT survey]. Rev Mal Respir. 2010;27(5):421–430.
   PubMed Web of Science ®Google Scholar
• Winter MC, Potter VA, Woll PJ. Raised serum urea predicts for early death in small cell lung cancer. Clin Oncol (R Coll Radiol). 2008;20(10):745–750.
   PubMed Web of Science ®Google Scholar
• Quoix E, Hedelin G, Popin E, et al. Can we predict very short term survival in small cell lung cancer? Lung Cancer. 1993;10(3–4):229–238.
   PubMed Web of Science ®Google Scholar
• Toker A, Dilege S, Ziyade S, et al. Causes of death within 1 year of resection for lung cancer. Early mortality after resection. Eur J Cardiothorac Surg. 2004;25(4):515–519.
   PubMed Web of Science ®Google Scholar
• Friedel G, Fritz P, Goletz S, et al. Postoperative survival of lung cancer patients: are there predictors beyond TNM? Anticancer Res. 2013;33(4):1609-1619.
   Web of Science ®Google Scholar
• Ludwig C, Stoelben E, Olschewski M, et al. Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non–small cell lung carcinoma. Ann Thorac Surg. 2013;68(3):968–973.
   Google Scholar
• Thomas P, Piraux M, Jacques LF, et al. Clinical patterns and trends of outcome of elderly patients with bronchogenic carcinoma. Eur J Cardiothorac Surg. 1998;13(3):266–274.
   PubMed Web of Science ®Google Scholar
• Baker S, Sharma A, Peric R, et al. Prediction of early mortality following stereotactic body radiotherapy for peripheral early-stage lung cancer. Acta Oncol. 2019;58(2):237–242.
   PubMed Web of Science ®Google Scholar
• Mansour Z, Kochetkova EA, Santelmo N, et al. Risk factors for early mortality and morbidity after pneumonectomy: a reappraisal. Ann Thorac Surg. 2009;88(6):1737–1743.
   PubMed Web of Science ®Google Scholar
• Stoelben E, Sauerbrei W, Ludwig C, et al. Tumor stage and early mortality for surgical resections in lung cancer. Langenbecks Arch Surg. 2003;388(2):116–121.
   PubMed Web of Science ®Google Scholar
• Tas F, Ciftci R, Kilic L, et al. Age is a prognostic factor affecting survival in lung cancer patients. Oncol Lett. 2013;6(5):1507–1513.
   PubMed Web of Science ®Google Scholar
• Jones GS, McKeever TM, Hubbard RB, et al. Factors influencing treatment selection and 30-day mortality after chemotherapy for people with small-cell lung cancer: an analysis of national audit data. Eur J Cancer. 2018;103:176–183.
   PubMed Web of Science ®Google Scholar
• Lundqvist A, Andersson E, Ahlberg I, et al. Socioeconomic inequalities in breast cancer incidence and mortality in Europe—a systematic review and meta-analysis. Eur J Public Health. 2016;26(5):804–813.
   PubMed Web of Science ®Google Scholar
• Finke I, Behrens G, Weisser L, et al. Socioeconomic differences and lung cancer survival—systematic review and meta-analysis. Front Oncol. 2018;8. DOI:https://doi.org/10.3389/fonc.2018.00536
   Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Aarts MJ, Lemmens VEPP, Louwman MWJ, et al. Socioeconomic status and changing inequalities in colorectal cancer? A review of the associations with risk, treatment and outcome. Eur J Cancer. 2010;19(15):2681–2695.
   Google Scholar
• Jochems A, El-Naqa I, Kessler M, et al. A prediction model for early death in non-small cell lung cancer patients following curative-intent chemoradiotherapy. Acta Oncol. 2018;57(2):226–230. .
   PubMed Web of Science ®Google Scholar
• Lin J, Carter CA, McGlynn KA, et al. A prognostic model to predict mortality among non–small-cell lung cancer patients in the U.S. military health system. J Thorac Oncol. 2015;10(12):1694–1702. .
   PubMed Web of Science ®Google Scholar
• The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409. .
   PubMed Web of Science ®Google Scholar
• Berghmans T, Lievens Y, Aapro M, et al. European cancer organisation Essential Requirements for Quality Cancer Care (ERQCC): lung cancer. Lung Cancer. 2020;150:221–239.
   PubMed Web of Science ®Google Scholar
• Tjong MC, Mak DY, Shahi J, et al. Current management and progress in radiotherapy for small cell lung cancer. Front Oncol. 10 14 July 2020;DOI:https://doi.org/10.3389/fonc.2020.01146
   Google Scholar
• Fiorino C, Guckemberger M, Schwarz M, et al. Technology-driven research for radiotherapy innovation. Mol Oncol. 2020;14(7):1500–1513.
   PubMed Web of Science ®Google Scholar
• Hosni M, García-Mateos G, Carrillo-de-gea JM, et al. A mapping study of ensemble classification methods in lung cancer decision support systems. Med Biol Eng Comput. 2020;58(10):2177–2193.
   PubMed Web of Science ®Google Scholar
• Christie JR, Lang P, Zelko LM, et al. Artificial intelligence in lung cancer: bridging the gap between computational power and clinical decision-making. Can Assoc Radiol J. 2021;72(1):86–97.
   PubMed Web of Science ®Google Scholar